Clene

CLNN

Market cap $126M

Overview Fund Trends Analyst Outlook Journalist POV

12.50 USD

+2.50

25%

At close Updated Oct 31, 4:00 PM EDT

Pre-market

After hours

11.76

--0.74

5.92%

1 day

25%

5 days

46.71%

1 month

107.3%

3 months

253.11%

6 months

320.88%

Year to date

131.91%

1 year

96.85%

5 years

-94.23%

10 years

-93.52%

About: Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Employees: 76

Consumer Staples Packaged Foods